-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - • Opioids are probably associated with increased
risk of short-term adverse events versus
nonopioid … Key Messages
• In the short term, improvement in pain and
function was small with specific
anticonvulsants … • At short-term followup, evidence showed no
differences between opioids versus nonopioid
medications … • Comprehensive programs were associated with
improvement in function in the short term
compared … • Few systematic reviews of acute pain
treatments examine outcomes other than very
short-term outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
January 01, 2005 - What are the short- and long-term adverse effects
associated with specific medical, surgical, and
endoscopic … This one study on Stretta™ versus sham had a
small number of patients and short duration of
followup … days
after the procedure—included chest or retrosternal
pain, gastrointestinal injury, bleeding, and short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
January 01, 2023 - In patients with chronic (mainly neuropathic) pain
with short-term treatment (4 weeks to <6 months): … Key Question 1: Benefits of cannabinoids for chronic pain compared with placebo
in the short term (4 … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo
in the short term (4 weeks … Implications and Conclusions
Select individuals with chronic neuropathic pain may experience small short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0161_09-01-2009.pdf
January 01, 2009 - cough, wheeze,
dyspnea); reduction or elimination of bronchodilator and inhaled steroid use in the short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
February 01, 2012 - examinations are used to make decisions
about further management: return to
normal screening/return for short-interval … mammography do not
have cancer, and significant numbers of healthy women are
referred for biopsy or short-interval … to near 0 percent, and therefore she might be assigned
to return to normal screening rather than short-interval … for clinicians to feel comfortable recommending return to
normal screening (rather than a biopsy or short-interval … Additional studies that enroll
women referred for short-interval followup after standard
workup are
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - In short-term randomized controlled trials (RCTs) (18 months to 3 years),
bisphosphonates, denosumab … In contrast, short-term drug
trials generally have not shown reduced fracture risk in postmenopausal … AHRQ review found that few published trials included at least half men, and that
these trials were short-term … In short-term RCTs and
observational studies, oral bisphosphonates increase upper gastrointestinal symptoms … for Osteoporosis Treatment and Prevention
Drug class Drug name Delivery
route
Dosing
frequency
Short
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
January 01, 2010 - Short- and long-term efficacy and effectiveness. … Rapidly released allergens from short ragweed pollen. I. … For the short ragweed pollen allergen extract FDA CBER reference
mite standard is assigned a specific … The amount
of Amb a 1 units are determined by an in-vitro comparison of a test short ragweed extract … CBER considered mandating a conversion to BAU/mL in the labeling of short ragweed pollen products, based
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
October 11, 2019 - I cannot imagine
any IRB approving an RCT of short-acting BDs vs placebo. … The message that we aimed to convey was that it is
unclear whether a combination of different short-acting … bronchodilators is more effective than one short-acting
bronchodilator alone. … See Evidence Summary: “Short-
acting beta adrenergic agonists (SABAs) and short-
acting muscarinic antagonists … beta agonists and short-
acting muscarinic antagonists is unclear.”
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
September 01, 2008 - Also, the requirement
for multiple injections of short-acting insulin (bolus
insulin) and long-acting … Short-acting human insulin (regular insulin)
administered prandially.
e. … • All the studies identified were of very short
duration. … of
increased mortality and cardiovascular morbidity
seen in the pooled estimates from the available
short-duration … 0.87 to
5.10) were found between premixed insulin analogues and
other diabetes medications in these short-duration
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
December 19, 2013 - variability in benefits
and harms depending on patient characteristics, opioid characteristics (e.g., short … In patients with chronic pain, what is the comparative effectiveness of short- versus
long-acting opioids … In patients with chronic pain, what is the comparative effectiveness of short- plus
long-acting opioids … treated with opioids for addiction
• Interventions:
Include:
• For KQs I, II, III: Long- or short-acting … For KQ IIIa: Comparisons of different dose initiation and titration
strategies
• For KQ IIIb: Short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - important
difference; MTX = methotrexate; PCS = physical component score; SF-36 = Medical Outcomes Study Short … baseline to endpoint (ACR 20), the
Health Assessment Questionnaire (HAQ), and Medical
Outcomes Study Short … = Health Assessment
Questionnaire; PCS = physical component score; SF-36 = Medical Outcomes Study Short … Questionnaire
MTX methotrexate
PsA psoriatic arthritis
RCT randomized controlled trial
SF-36 PCS Short
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
February 01, 2019 - showed the most promise at
improving the health of older adults; however, effects were inconsistent and short-term … most promise at improving the health of older adults; however, effects were inconsistent and
studies short … One study41 measured outcomes at 3
weeks, which was too short to see an effect on certain important … Data collected at baseline and 6
months:
• Depression (Geriatric Depression
Scale short form)
• … • Mean score of 7.70
from the short form of
the Geriatric
Depression Scale (not
clear whether
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
January 01, 2024 - In
patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to
<6 months) … Key Question 1: Benefits of cannabinoids for chronic pain compared with placebo in the
short term (4 … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo in the
short term (4 weeks … Implications and Conclusions
Select individuals with chronic neuropathic pain may experience small short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
January 01, 2011 - vasoreactivity, biomarker)
for guiding the diagnosis and management of PAH as well as for use in evaluating
short
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
January 01, 2008 - EHC Program focus on key long-term, real life effectiveness
trials and comparative harms rather than short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0261_07-16-2010.pdf
January 01, 2010 - adherence; outcomes of improved guideline
adherence, including prescriptions for appropriate controllers, short
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
April 01, 2010 - Dyspnea DEcIDE
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists healt…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
February 01, 2012 - All randomized and open-label trials
and three case series evaluated the short-term outcome
of reduction … The
trials were short, with treatment between 1 and 8 weeks,
and dosages ranged from 250 mg/kg/day … 47), and there is no evidence that Phe
levels were reduced to clinically meaningful levels in the
short … The expanded registry could include, but need
not be limited to, data on short- and long-term outcomes … multicenter
consortium, registry, and biorepository, PKU could serve
as a model for studying the short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/models-care-adult-survivors-childhood-cancer-evidence-summary.pdf
February 01, 2022 - systems are (1)
what models of childhood cancer survivorship care that include primary care may improve short … Our review was also limited by the relatively short amount
4
of time available
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
February 01, 2014 - KQ 2: Do these regimens differ in reaching LDL targets
(or other surrogate markers), short-term side … Most trials included in this
report were of relatively short duration (<3 months). … The evidence base was also limited due to the short
duration of most studies. … Most trials we identified were
of relatively short duration, despite the fact that these
medications … Short-term trials using surrogate endpoints are of
diminishing value at this point.